Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations

NCT03918850 is registered in ClinicalTrials.gov with T. John Winhusen, PhD as lead sponsor.

NCT NCT03918850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03918850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations
Lead sponsor
T. John Winhusen, PhD
Phase
Phase 3
Overall status
Completed
Start date
July 21, 2020
Completion date
January 31, 2025
Enrollment
140 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, drug abuse in pregnancy, drug addiction, neonatal abstinence syndrome, neonatal opioid withdrawal syndrome, opioid-related disorders, pregnancy related, substance abuse